Inhibition of CHK1 and WEE1 as a new therapeutic approach in diffuse large B cell lymphomas with MYC deregulation

被引：15

作者：

Restelli, Valentina ^{[1
]}

Vagni, Micaela ^{[1
]}

Arribas, Alberto J. ^{[2
]}

Bertoni, Francesco ^{[2
,3
]}

Damia, Giovanna ^{[1
]}

Carrassa, Laura ^{[1
]}

机构：

[1] IRCCS, Ist Ric Farmacol Mario Negri, Dept Oncol, Lab Mol Pharmacol, Milan, Italy

[2] IOR Inst Oncol Res, Lymphoma & Genom Res Program, Bellinzona, Switzerland

[3] IOSI Oncol Inst Southern Switzerland, Bellinzona, Switzerland

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2018年 / 181卷 / 01期

关键词：

diffuse large B cell lymphoma; CHK1; WEE1; MYC; combined targeted therapy; PHASE; COMBINATION; CANCER;

D O I：

10.1111/bjh.14506

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：129 / 133

页数：5

共 10 条

[1] Rearrangement of MYC Is Associated With Poor Prognosis in Patients With Diffuse Large B-Cell Lymphoma Treated in the Era of Rituximab [J].

Barrans, Sharon ;

Crouch, Simon ;

Smith, Alex ;

Turner, Kathryn ;

Owen, Roger ;

Patmore, Russell ;

Roman, Eve ;

Jack, Andrew .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (20) :3360-3365

[2] Distinct but Concerted Roles of ATR, DNA-PK, and Chk1 in Countering Replication Stress during S Phase [J].

Buisson, Remi ;

Boisvert, Jessica L. ;

Benes, Cyril H. ;

Zou, Lee .

MOLECULAR CELL, 2015, 59 (06) :1011-1024

[3] Combined inhibition of Chk1 and Wee1 In vitro synergistic effect translates to tumor growth inhibition in vivo [J].

Carrassa, Laura ;

Chila, Rosaria ;

Lupi, Monica ;

Ricci, Francesca ;

Celenza, Cinzia ;

Mazzoletti, Marco ;

Broggini, Massimo ;

Damia, Giovanna .

CELL CYCLE, 2012, 11 (13) :2507-2517

[4] Combined inhibition of Chk1 and Wee1 as a new therapeutic strategy for mantle cell lymphoma [J].

Chila, Rosaria ;

Basana, Alessandra ;

Lupi, Monica ;

Guffanti, Federica ;

Gaudio, Eugenio ;

Rinaldi, Andrea ;

Cascione, Luciano ;

Restelli, Valentina ;

Tarantelli, Chiara ;

Bertoni, Francesco ;

Damia, Giovanna ;

Carrassa, Laura .

ONCOTARGET, 2015, 6 (05) :3394-3408

[5] Phase I Dose-Escalation Trial of Checkpoint Kinase 1 Inhibitor MK-8776 As Monotherapy and in Combination With Gemcitabine in Patients With Advanced Solid Tumors [J].

Daud, Adil I. ;

Ashworth, Michelle T. ;

Strosberg, Jonathan ;

Goldman, Jonathan W. ;

Mendelson, David ;

Springett, Gregory ;

Venook, Alan P. ;

Loechner, Sabine ;

Rosen, Lee S. ;

Shanahan, Frances ;

Parry, David ;

Shumway, Stuart ;

Grabowsky, Jennifer A. ;

Freshwater, Tomoko ;

Sorge, Christopher ;

Kang, Soonmo Peter ;

Isaacs, Randi ;

Munster, Pamela N. .

JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (09) :1060-+

[6] Therapeutic Implications for the Induced Levels of Chk1 in Myc-Expressing Cancer Cells [J].

Hoeglund, Andreas ;

Nilsson, Lisa M. ;

Muralidharan, Somsundar Veppil ;

Hasvold, Lisa A. ;

Merta, Philip ;

Rudelius, Martina ;

Nikolova, Viktoriya ;

Keller, Ulrich ;

Nilsson, Jonas A. .

CLINICAL CANCER RESEARCH, 2011, 17 (22) :7067-7079

[7] Stromal Gene Signatures in Large-B-Cell Lymphomas [J].

Lenz, G. ;

Wright, G. ;

Dave, S. S. ;

Xiao, W. ;

Powell, J. ;

Zhao, H. ;

Xu, W. ;

Tan, B. ;

Goldschmidt, N. ;

Iqbal, J. ;

Vose, J. ;

Bast, M. ;

Fu, K. ;

Weisenburger, D. D. ;

Greiner, T. C. ;

Armitage, J. O. ;

Kyle, A. ;

May, L. ;

Gascoyne, R. D. ;

Connors, J. M. ;

Troen, G. ;

Holte, H. ;

Kvaloy, S. ;

Dierickx, D. ;

Verhoef, G. ;

Delabie, J. ;

Smeland, E. B. ;

Jares, P. ;

Martinez, A. ;

Lopez-Guillermo, A. ;

Montserrat, E. ;

Campo, E. ;

Braziel, R. M. ;

Miller, T. P. ;

Rimsza, L. M. ;

Cook, J. R. ;

Pohlman, B. ;

Sweetenham, J. ;

Tubbs, R. R. ;

Fisher, R. I. ;

Hartmann, E. ;

Rosenwald, A. ;

Ott, G. ;

Muller-Hermelink, H. -K ;

Wrench, D. ;

Lister, T. A. ;

Jaffe, E. S. ;

Wilson, W. H. ;

Chan, W. C. ;

Staudt, L. M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (22) :2313-2323

[8] Proteasomal Inhibition by Ixazomib Induces CHK1 and MYC-Dependent Cell Death in T-cell and Hodgkin Lymphoma [J].

Ravi, Dashnamoorthy ;

Beheshti, Afshin ;

Abermil, Nassera ;

Passero, Frank ;

Sharma, Jaya ;

Coyle, Michael ;

Kritharis, Athena ;

Kandela, Irawati ;

Hlatky, Lynn ;

Sitkovsky, Michail V. ;

Mazar, Andrew ;

Gartenhaus, Ronald B. ;

Evens, Andrew M. .

CANCER RESEARCH, 2016, 76 (11) :3319-3331

[9] Phase II evaluation of LY2603618, a first-generation CHK1 inhibitor, in combination with pemetrexed in patients with advanced or metastatic non-small cell lung cancer [J].

Scagliotti, Giorgio ;

Kang, Jin Hyoung ;

Smith, David ;

Rosenberg, Richard ;

Park, Keunchil ;

Kim, Sang-We ;

Su, Wu-Chou ;

Boyd, Thomas E. ;

Richards, Donald A. ;

Novello, Silvia ;

Hynes, Scott M. ;

Myrand, Scott P. ;

Lin, Ji ;

Smyth, Emily Nash ;

Wijayawardana, Sameera ;

Lin, Aimee Bence ;

Pinder-Schenck, Mary .

INVESTIGATIONAL NEW DRUGS, 2016, 34 (05) :625-635

[10] Genetic lesions in diffuse large B-cell lymphomas [J].

Testoni, M. ;

Zucca, E. ;

Young, K. H. ;

Bertoni, F. .

ANNALS OF ONCOLOGY, 2015, 26 (06) :1069-1080

← 1 →